Next Article in Journal / Special Issue
Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
Previous Article in Journal / Special Issue
Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer
Review

Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer

1
Advanced Institutes of Convergence Technology, Suwon, Kyeonggi-do 443-270, Korea
2
Department of Pharmacy, College of Pharmacy, Seoul National University, Seoul 151-742, Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2011, 12(2), 983-1008; https://doi.org/10.3390/ijms12020983
Received: 15 December 2010 / Revised: 19 January 2011 / Accepted: 28 January 2011 / Published: 31 January 2011
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer)
The involvement of epigenetic aberrations in the development and progression of tumors is now well established. However, most studies have focused on the epigenetic inactivation of tumor suppressor genes during tumorigenesis and little is known about the epigenetic activation of cancer-associated genes, except for the DNA hypomethylation of some genes. Recently, we reported that the overexpression of cancer-promoting genes in ovarian cancer is associated with the loss of repressive histone modifications. This discovery suggested that epigenetic derepression may contribute to ovarian tumorigenesis by constituting a possible mechanism for the overexpression of oncogenes or cancer-promoting genes in tumors. The emerging importance of epigenetic aberrations in tumor initiation and in the regulation of cancer-initiating cells, suggests that epigenetically regulated genes may be promising therapeutic targets and biomarkers. Given that the current challenges in ovarian cancer include the identification of biomarkers for early cancer detection and the discovery of novel therapeutic targets for patients with recurrent malignancies undergoing chemotherapy, understanding the epigenetic changes that occur in ovarian cancer is crucial. This review looks at epigenetic mechanisms involved in the regulation of cancer-associated genes, including the contribution of epigenetic derepression to the activation of cancer-associated genes in ovarian cancer. In addition, possible epigenetic therapies targeting epigenetically dysregulated genes are discussed. A better understanding of the epigenetic changes in ovarian cancer will contribute to the improvement of patient outcomes. View Full-Text
Keywords: ovarian cancer; epigenetic derepression; DNA methylation; histone modification; miRNA; epigenetic therapy; chemoresistance; cancer-initiating cells ovarian cancer; epigenetic derepression; DNA methylation; histone modification; miRNA; epigenetic therapy; chemoresistance; cancer-initiating cells
Show Figures

Graphical abstract

MDPI and ACS Style

Kwon, M.J.; Shin, Y.K. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer. Int. J. Mol. Sci. 2011, 12, 983-1008. https://doi.org/10.3390/ijms12020983

AMA Style

Kwon MJ, Shin YK. Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer. International Journal of Molecular Sciences. 2011; 12(2):983-1008. https://doi.org/10.3390/ijms12020983

Chicago/Turabian Style

Kwon, Mi Jeong, and Young Kee Shin. 2011. "Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer" International Journal of Molecular Sciences 12, no. 2: 983-1008. https://doi.org/10.3390/ijms12020983

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop